Choksi Laboratories Ltd (CHOKSILA) is currently trading at 198.75 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Choksi Laboratories Limited provides contract testing and analytical services across pharmaceuticals, food, agriculture, construction materials, chemicals, calibration and environment monitoring, operating multiple laboratories and offering in‑house lab setup, consultancy and audit services to industry clients with traceability to national and international calibration standards. Quarter ended 30 June 2026 reported total revenue of INR 1,207.89 lakhs, profit before tax of INR 59.93 lakhs and net profit of INR 58.24 lakhs, with earnings per share of INR 0.84; the Board approved the results on 13 August 2026 and the limited review report contained no qualifications. Cost structure shows material fixed and semi‑fixed charges: employee benefits at INR 488.29 lakhs and depreciation at INR 197.04 lakhs alongside finance costs of INR 73.08 lakhs, which together compress operating profitability despite steady revenue and underline sensitivity of margins to utilization and pricing. Regulatory credentialing is a clear growth catalyst: the company received enhanced CDSCO approval to test 69 types of medical devices in FY2025, expanding the addressable testing market, enabling higher‑value regulatory work and potentially improving realization per test if volumes scale across clients.

Over the past 52 weeks, Choksi Laboratories Ltd has traded between a low of ₹81.85 and a high of ₹227.90. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Choksi Laboratories Ltd has a market capitalization of approximately 138.33. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Choksi Laboratories Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 64.04 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 138.33 Cr, Choksi Laboratories Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Choksi Laboratories Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Choksi Laboratories Ltd is 64.04. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.